MANNKIND CORP Employee Count
The employee counts MANNKIND CORP states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 592; Filing 2026-02-26; Lease expense per employee $6,312.50.
- 2024-12-31: Employees (as filed) 407; Filing 2025-02-26; Lease expense per employee $5,742.01.
- 2023-12-31: Employees (as filed) 414; Filing 2024-02-27; Lease expense per employee $4,297.10.
- 2022-12-31: Employees (as filed) 395; Filing 2023-02-23; Lease expense per employee $4,554.43.
- Available history
- 2008-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 592 full-time | 2026-02-26 | $6,312.50 operating + variable |
| 2024-12-31 | 407 full-time | 2025-02-26 | $5,742.01 operating + variable |
| 2023-12-31 | 414 full-time | 2024-02-27 | $4,297.10 operating + variable |
| 2022-12-31 | 395 full-time | 2023-02-23 | $4,554.43 operating + variable |
| 2021-12-31 | 349 full-time | 2022-02-24 | $5,154.73 operating + variable |
| 2020-12-31 | 241 full-time | 2021-02-25 | $7,456.43 operating + variable |
| 2019-12-31 | 233 full-time | 2020-02-25 | $8,154.51 operating + variable |
| 2018-12-31 | 225 full-time | 2019-02-26 | $2,222.22 rent expense, net |
| 2017-12-31 | 250 full-time | 2018-02-27 | $1,600.00 rent expense, net |
| 2016-12-31 | 153 full-time | 2017-03-16 | $2,614.38 rent expense, net |
| 2015-12-31 | 192 full-time | 2016-03-15 | $2,083.33 rent expense, net |
| 2014-12-31 | 124 full-time | 2015-03-02 | $5,943.55 rent expense, net |
| 2013-12-31 | 265 full-time | 2014-03-03 | $2,433.96 rent expense, net |
| 2012-12-31 | 246 full-time | 2013-03-18 | $2,743.90 rent expense, net |
| 2011-12-31 | 250 full-time | 2012-03-15 | $3,064.00 rent expense, net |
| 2010-12-31 | 436 full-time | 2011-03-16 | $2,752.29 rent expense, net |
| 2009-12-31 | 443 full-time | 2010-03-16 | |
| 2008-12-31 | 580 full-time | 2009-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |